Mycophenolate mofetil in patients with Crohn's disease

American Journal of Gastroenterology

Volumn 93, Issue 12, 1998, Pages 2529-2532

  Fickert, Peter ^a   Hinterleitner, Thomas Anton ^a   Wenzl, Heimo Helmut ^a   Aichbichler, Berendt Winfred ^a   Petritsch, Wolfgang ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DIARRHEA; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RETREATMENT; TREATMENT OUTCOME;

EID: 0032416705     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00606.x     Document Type: Article

References (16)

1. 1. Pearson DC, May GR, Fick GH, et al. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 122: 132-42.
2. 2. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980;302:981-7.
3. 3. Ewe K, Press AG, Singe CC, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology 1993;105:367-27.
4. 4. Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334: 841-8.
5. 5. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 1995;91:423-33.
6. 6. Sandborn W. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995;1:48-63.
7. 7. Lipsky JJ. Mycophenolate mofetil. Lancet 1995;348:1357-9.
8. 8. Sollinger HW, for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995;60:225-32.
9. 9. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995;345: 1321-5.
10. 10. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 1993;11:117-9.
11. 11. Epinette WW, Parker CM, Jones EL, et al. Mycophenolic acid for psoriasis. J Am Acad Dermatol 1987;17:962-71.
12. 12. Horgan K. Initial experience with mycophenolate mofetil in the treatment of severe inflammatory bowel disease. Gastroenterology 1997; 112(suppl):A999.
13. 13. Neurath MF, Duchmann R, Peters M, et al. Mycophenolate mofetil/cortison versus azathioprine/cortison for treatment of active inflammatory bowel disease: Preliminary results of a prospective randomised study. Gut 1997;41(suppl 3):P822.
14. 14. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. J Clin Gastroenterol 1995;20: 27-32.
15. 15. Best WR, Becktel JM, Singleton JW, et al. Development of Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
16. 16. Bouhnik Y, Lemann M, Mary JY, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;347:215-9.